Flow cytometry analysis showed that knockdown of Rpl29 significantly decreased the leukemia burden and eliminated LSPCs in BM and spleen of secondary CML mice (Figure S10F–K, Supporting Information). The gene discussed is RPL29; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.